Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
Article 2021 en
Authors
PC
Philippe A. Cassier
CP
Clémentine Peyramaure
VA
Valéry Attignon
Abstract
1 min read
Genomic profiling for patients with advanced gastroesophageal cancers allows the identification of actionable alterations in large proportion of patients. Increased accessibility to molecularly matched therapy may improve survival in this disease.
Armelle Vinceneux, Guillaume Moriceau, Marianne Lorcet, Mélodie Carbonnaux, Philippe A. Cassier, C. Terret, Christian Baudet, Valéry Attignon, Daniel Pissaloux, Sylvie Chabaud, Qing Wang, David Pérol, Olivier Trédan, Jean Yves Blay, Sylvie Négrier, Helen Jane Boyle, Aude Fléchon
Patrick Arnaud‐Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Trédan, Valéry Attignon, Daniel Pissaloux, Emilie Sohier, Philippe A. Cassier, Gwenaëlle Garin, David Pérol, Jean Yves Blay, Armelle Dufresne
Elise F. Nassif, Édouard Auclin, Rastilav Bahleda, Charles Honoré, Olivier Mir, Sarah Dumont, Benoîte Méry, Khalil Hodroj, Mehdi Brahmi, Olivier Trédan, Isabelle Ray‐Coquard, Jean Yves Blay, Christophe Massard, Axel Le Cesne, Armelle Dufresne
Discussion(0)
No comments yet. Be the first to comment.